Gene expression based classification of gastric carcinoma

Cancer Letters

Volumn 210, Issue 2, 2004, Pages 227-237

  Nørsett, Kristin G ^a   Lægreid, Astrid ^a   Midelfart, Herman ^a,b   Yadetie, Fekadu ^a   Erlandsen, Sten Even ^a   Falkmer, Sture ^a   Grønbech, Jon E ^a   Waldum, Helge L ^a   Komorowski, Jan ^a,b   Sandvik, Arne K ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

cDNA microarray; Gastric cancer; Learning; Prognosis

Indexed keywords

COMPLEMENTARY DNA; MOLECULAR MARKER;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CANCER CLASSIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE PROBE; GENETIC ANALYSIS; GROWTH; HUMAN; HUMAN TISSUE; INTESTINE; LYMPH NODE METASTASIS; MALE; NUCLEOTIDE SEQUENCE; PARAMETER; PREDICTION; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; STOMACH CARCINOMA; UNINDEXED SEQUENCE;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS;

EID: 2942588690     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.01.022     Document Type: Article

References (49)

1. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal type. Acta Pathol. Microbiol. Scand. [A]. 1965;31-49
2. Chan A.O., Luk J.M., Hui W.M., Lam S.K. Molecular biology of gastric carcinoma: from laboratory to bedside. J. Gastroenterol. Hepatol. 1999;1150-1160
3. Guilford P., Hopkins J., Harraway J., McLeod M., McLeod N., Harawira P., et al. E-cadherin germline mutations in familial gastric cancer. Nature. 1998;402-405
4. Fujita K., Ohuchi N., Yao T., Okumura M., Fukushima Y., Kanakura Y., et al. Frequent overexpression, but not activation by point mutation, of ras genes in primary human gastric cancers. Gastroenterology. 1987;1339-1345
5. Akama Y., Yasui W., Yokozaki H., Kuniyasu H., Kitahara K., Ishikawa T., Tahara E. Frequent amplification of the cyclin E gene in human gastric carcinomas. Jpn. J. Cancer Res. 1995;617-621
6. Tahara E. Growth factors and oncogenes in human gastrointestinal carcinomas. J. Cancer Res. Clin. Oncol. 1990;121-131
7. Yonemura Y., Takamura H., Ninomiya I., Fushida S., Tsugawa K., Kaji M., et al. Interrelationship between transforming growth factor-alpha and epidermal growth factor receptor in advanced gastric cancer. Oncology. 1992;157-161
8. Taniguchi T., Kitamura M., Arai K., Iwasaki Y., Yamamoto Y., Igari A., Toi M. Increase in the circulating level of hepatocyte growth factor in gastric cancer patients. Br. J. Cancer. 1997;673-677
9. Kuniyasu H., Yasui W., Yokozaki H., Kitadai Y., Tahara E. Aberrant expression of c-met mRNA in human gastric carcinomas. Int. J. Cancer. 1993;72-75
10. Han H.J., Yanagisawa A., Kato Y., Park J.G., Nakamura Y. Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. Cancer Res. 1993;5087-5089
11. Yoshida Y., Itoh F., Endo T., Hinoda Y., Imai K. Decreased DCC mRNA expression in human gastric cancers is clinicopathologically significant. Int. J. Cancer. 1998;634-639
12. Pawlak Z. Rough Sets: Theoretical Aspects of Reasoning about Data. 1991;Kluwer, Dordrecht
13. Komorowski J., Skowron A., Øhrn A. Rosetta rough set software system. Klösgen W., Zytkow J. Handbook of Data Mining and Knowledge Discovery. 2001;Oxford University Press, Oxford
14. Kleveland P.M., Haugen S.E., Waldum H.L. The preparation of bioactive 125I-gastrin, using Iodo-gen as oxidizing agent, and the use of this tracer in receptor studies. Scand. J. Gastroenterol. 1985;569-576
15. Yadetie F., Laegreid A., Bakke I., Kusnierczyk W., Komorowski J., Waldum H.L., Sandvik A.K. Liver gene expression in rats in response to the peroxisome proliferator-activated receptor-alpha agonist ciprofibrate. Physiol. Genomics. 2003;9-19
16. Yang Y.H., Dudoit S., Luu P., Speed T.P. Normalization for cDNA Microarray Data. 2001;SPIE BiOS, San Jose, CA
17. Efron B., Tibshirani R.J. An Introduction to the Bootstrap. Monographs on Statistics and Applied Probability (57). 1993;Chapman and Hall, New York
18. Fayyad U.M., Irani K.B. Multi-interval discretization of continuous-valued attributes for classification learning. Bajcsy R. Proceedings of the 13th International Joint Conference of Artificial Intelligence. 1993;1022-1027 Morgan Kaufmann, San Fransisco
19. Golub T.R., Slonim D.K., Tamayo P., Huard C., Gaasenbeek M., Mesirov J.P., et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 1999;531-537
20. Ben-Dor A., Bruhn L., Friedman N., Nachman I., Schummer M., Yakhini Z. Tissue classification with gene expression profiles. J. Comput. Biol. 2000;559-583
21. Midelfart H., Komorowski J., Nørsett K.G., Yadetie F., Sandvik A.K., Laegreid A. Learning rough set classifiers from gene expression and clinical data. Fundamenta Informaticae. 2002;155-183
22. Figer A., Irmin L., Geva R., Flex D., Sulkes J., Sulkes A., Friedman E. The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel. Br. J. Cancer. 2001;478-481
23. Yanagimoto K., Sato Y., Shimoyama Y., Tsuchiya B., Kuwao S., Kameya T. Co-expression of N-cadherin and alpha-fetoprotein in stomach cancer. Pathol. Int. 2001;612-618
24. Bussemakers M.J. Changes in gene expression and targets for therapy. Eur. Urol. 1999;408-412
25. Nieman M.T., Prudoff R.S., Johnson K.R., Wheelock M.J. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J. Cell Biol. 1999;631-644
26. Royal I., Lamarche-Vane N., Lamorte L., Kaibuchi K., Park M. Activation of cdc42, rac, PAK, and rho-kinase in response to hepatocyte growth factor differentially regulates epithelial cell colony spreading and dissociation. Mol. Biol. Cell. 2000;1709-1725
27. So J.B., Samarasinge K., Raju G.C., Moochhala S.M., Ti T.K. Expression of cell-cycle regulators p27 and cyclin E correlates with survival in gastric carcinoma patients. J. Surg. Res. 2000;56-60
28. Yokose T., Doy M., Taniguchi T., Shimada T., Kakiki M., Horie T., et al. Immunohistochemical study of cytochrome P450 2C and 3A in human non-neoplastic and neoplastic tissues. Virchows Arch. 1999;401-411
29. Sasaki N., Morisaki T., Hashizume K., Yao T., Tsuneyoshi M., Noshiro H., et al. Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin. Cancer Res. 2001;4136-4142
30. Higham A.D., Bishop L.A., Dimaline R., Blackmore C.G., Dobbins A.C., Varro A., et al. Mutations of RegIalpha are associated with enterochromaffin- like cell tumor development in patients with hypergastrinemia. Gastroenterology. 1999;1310-1318
31. Nakamura M., Inufusa H., Adachi T., Aga M., Kurimoto M., Nakatani Y., et al. Involvement of galectin-3 expression in colorectal cancer progression and metastasis. Int. J. Oncol. 1999;143-148
32. Le Marer N., Hughes R.C. Effects of the carbohydrate-binding protein galectin-3 on the invasiveness of human breast carcinoma cells. J. Cell Physiol. 1996;51-58
33. Rzeski W., Turski L., Ikonomidou C. Glutamate antagonists limit tumor growth. Proc. Natl Acad. Sci. USA. 2001;6372-6377
34. Dudoit S., Fridlyand J., Speed T.P. Comparison of discrimination methods for the classification of tumors using gene expression data. J. Am. Statistical Assoc. 2002;77-87
35. Hippo Y., Taniguchi H., Tsutsumi S., Machida N., Chong J.M., Fukayama M., et al. Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res. 2002;233-240
36. El-Rifai W., Frierson H.F.J., Harper J.C., Powell S.M., Knuutila S. Expression profiling of gastric adenocarcinoma using cDNA array. Int. J. Cancer. 2001;832-838
37. Hong S.I., Park I.C., Hong W.S., Son Y.S., Lee S.H., Lee J.I., et al. Overexpression of tissue inhibitors of metalloproteinase-1 and -2 in the stroma of gastric cancer. J. Korean Med. Sci. 1996;474-479
38. Yoshida K., Yasui W., Ito H., Tahara E. Growth factors in progression of human esophageal and gastric carcinomas. Exp. Pathol. 1990;291-300
39. Boussioutas A., Li H., Liu J., Waring P., Lade S., Holloway A.J., et al. Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer. Cancer Res. 2003;2569-2577
40. Wang H.H., Antonioli D.A., Goldman H. Comparative features of esophageal and gastric adenocarcinomas: recent changes in type and frequency. Hum. Pathol. 1986;482-487
41. Botterweck A.A., Schouten L.J., Volovics A., Dorant E., van Den Brandt P.A. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int. J. Epidemiol. 2000;645-654
42. Kadowaki Y., Ishihara S., Miyaoka Y., Rumi M.A., Sato H., Kazumori H., et al. Reg protein is overexpressed in gastric cancer cells, where it activates a signal transduction pathway that converges on ERK1/2 to stimulate growth. Fed. Eur. Biochem. Soc. Lett. 2002;59-64
43. Perou C.M., Sorlie T., Eisen M.B., Van de Rijn M., Jeffrey S.S., Rees C.A., et al. Molecular portraits of human breast tumours. Nature. 2000;747-752
44. Alizadeh A.A., Eisen M.B., Davis R.E., Ma C., Lossos I.S., Rosenwald A., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;503-511
45. Kihara C., Tsunoda T., Tanaka T., Yamana H., Furukawa Y., Ono K., et al. Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles. Cancer Res. 2001;6474-6479
46. Gruvberger S., Ringner M., Chen Y., Panavally S., Saal L.H., Borg A., et al. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res. 2001;5979-5984
47. Hedenfalk I., Duggan D., Chen Y., Radmacher M., Bittner M., Simon R., et al. Gene-expression profiles in hereditary breast cancer. N. Engl. J. Med. 2001;539-548
48. West M., Blanchette C., Dressman H., Huang E., Ishida S., Spang R., et al. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc. Natl Acad. Sci. USA. 2001;11462-11467
49. Takahashi M., Rhodes D.R., Furge K.A., Kanayama H., Kagawa S., Haab B.B., Teh B.T. Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc. Natl Acad. Sci. USA. 2001;9754-9759